Repurposed Antiviral Drugs for Covid-19 – Interim WHO Solidarity Trial Results.

Pan, H; Peto, R; Henao-Restrepo, AM; Preziosi, MP; Sathiyamoorthy, V; Abdool Karim, Q; Alejandria, MM; Hernández García, C; Kieny, MP; Malekzadeh, R; Murthy, S; Reddy, KS; Roses Periago, M; Abi Hanna, P; Ader, F; Al-Bader, AM; Alhasawi, A; Allum, E; Alotaibi, A; Alvarez-Moreno, CA; Appadoo, S; Asiri, A; Aukrust, P; Barratt-Due, A; Bellani, S; Branca, M; Cappel-Porter, HBC; Cerrato, N; Chow, TS; Como, N; Eustace, J; García, PJ; Godbole, S; Gotuzzo, E; Griskevicius, L; Hamra, R; Hassan, M; Hassany, M; Hutton, D; Irmansyah, I; Jancoriene, L; Kirwan, J; Kumar, S; Lennon, P; Lopardo, G; Lydon, P; Magrini, N; Maguire, T; Manevska, S; Manuel, O; McGinty, S; Medina, MT; Mesa Rubio, ML; Miranda-Montoya, MC; Nel, J; Nunes, EP; Perola, M; Portolés, A; Rasmin, MR; Raza, A; Rees, H; Reges, PPS; Rogers, CA; Salami, K; Salvadori, MI; Sinani, N; Sterne, JAC; Stevanovikj, M; Tacconelli, E; Tikkinen, KAO; Trelle, S; Zaid, H; Røttingen, JA; Swaminathan, S;

View this publication in the PUBMED database